ondansetron has been researched along with Bone Marrow Diseases in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Bone Marrow Diseases: Diseases involving the BONE MARROW.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomollón, F | 1 |
| Rubio, S | 1 |
| Charro, M | 1 |
| García-López, S | 1 |
| Muñoz, F | 1 |
| Gisbert, JP | 1 |
| Domènech, E | 1 |
1 other study available for ondansetron and Bone Marrow Diseases
| Article | Year |
|---|---|
[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
Topics: Adult; Antiemetics; Antirheumatic Agents; Bone Marrow Diseases; Chemical and Drug Induced Liver Inju | 2015 |